Heron Therapeutics Inc

NEW
FRA:AXD2 (USA)   Ordinary Shares
€ 0.40 -0.0072 (-1.78%) Jul 24
At Loss
P/B:
10.60
Market Cap:
€ 75.84M ($ 86.21M)
Enterprise V:
€ 161.89M ($ 184.04M)
Volume:
2.20K
Avg Vol (2M):
4.16K
Trade In:
Volume:
2.20K
At Loss
Avg Vol (2M):
4.16K

Heron Therapeutics Inc (FRA:AXD2) Dividend

Heron Therapeutics Inc (FRA:AXD2) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -16.5%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:AXD2 Dividend

Does Heron Therapeutics Inc (FRA:AXD2) pay a dividend?

Heron Therapeutics Inc (FRA:AXD2) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Heron Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Heron Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -16.5% over the past 3 years.

What are dividend-paying alternatives to Heron Therapeutics Inc?

For dividend-paying alternatives in Heron Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.